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Dear Collegues,
The current SARS-CoV-2 virus (COVID-19) pandemic has become one of the greatest health 
challenges facing the world in 2020. Cancer patients are a heterogeneous group, and the type of 
systemic and local treatment may affect their immune response and the course of any infection. 
In the group of high risk of severe course of SARS-CoV-2 infection, there are undoubtedly cancer 
patients with many comorbidities, especially cardiovascular and pulmonary diseases, in old age 
and in the advanced stage of the disease. Although the impact of oncological treatment on the 
course of SARS-CoV-2 infection remains unclear, international guidelines recommend postponing 
chemotherapy or elective surgery in specific indications in endemic areas. During the SARS-CoV-2 
pandemic, the oncological community continued its work despite numerous challenges in the 
functioning of medical care. To meet the expectations of our community and to present and analyze 
our own experience in cancer patients therapy and SARS-CoV-2 infection, the Oncology in Clinical 
Practice journal invites you to submit short case reports in the Clinical vignettes on COVID-19 format. 
We hope that the presented clinical experiences will contribute to the improvement of cancer care.
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